Hydroxychloroquine is associated with lower seroconversion upon 17DD-Yellow fever primovaccination in patients with primary Sjögren's syndrome

• Main Authors: Ketty Lysie Libardi Lira Machado (Author), Ismael Artur da Costa-Rocha (Author), Laura Gonçalves Rodrigues Aguiar (Author), Isac Ribeiro Moulaz (Author), Samira Tatiyama Miyamoto (Author), Priscila Costa Martins (Author), Erica Vieira Serrano (Author), Ana Paula Espíndula Gianordoli (Author), Maria da Penha Gomes Gouvea (Author), Maria de Fatima Bissoli (Author), Sheila Maria Barbosa de Lima (Author), Waleska Dias Schwarcz (Author), Adriana de Souza Azevedo (Author), Juliana Fernandes Amorim da Silva (Author), Renata Tourinho Santos (Author), Joaquim Pedro Brito- (Author), Jordana Grazziela Coelho- (Author), Ana Carolina Campi-Azevedo (Author), Andréa Teixeira-Carvalho (Author), Vanessa Peruhype-Magalhães (Author), Francieli Fontana Sutile Tardetti Fantinato (Author), Licia Maria Henrique da Mota (Author), Olindo Assis Martins-Filho (Author), Valéria Valim (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The present study aimed at investigating whether the hydroxychloroquine (HCQ) treatment would impact the neutralizing antibody production, viremia levels and the kinetics of serum soluble mediators upon planned 17DD-Yellow Fever (YF) primovaccination (Bio-Manguinhos-FIOCRUZ) of primary Sjögren'...